MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/heartjnl-2018-312950

Медицинская библиотека · Heart (British Cardiac Society) · 2018

Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction.

Beygui Farzin, Van Belle Eric, Ecollan Patrick, Machecourt Jacques, Hamm Christian W, Lopez De Sa Estaeban, Flather Marcus, Verheugt Freek W A, Vicaut Eric, Zannad Faiez, Pitt Bertram, Montalescot Gilles

СтатьяМетаанализПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Two recent randomised trials studied the benefit of mineralocorticoid receptor antagonists (MRAs) in ST-segment elevation myocardial infarction (STEMI) irrespective or in absence of heart failure. The studies were both undersized to assess hard clinical endpoints. A pooled analysis was preplanned by the steering committees.

METHODS

We conducted a prespecified meta-analysis of patient-level data of patients with STEMI recruited in two multicentre superiority trials, randomised within 72 hours after symptom onset. Patients were allocated (1:1) to two MRA regimens: (1) an intravenous bolus of potassium canrenoate (200 mg) followed by oral spironolactone (25 mg once daily) versus standard therapy or (2) oral eplerenone (25-50 mg) versus placebo. The primary and key secondary outcomes, all-cause death and the composite of all-cause death or resuscitated sudden death, respectively, were assessed in the intention-to-treat population using a Cox model stratified on the study identifier.

RESULTS

Patients were randomly assigned to receive (n=1118) or not the MRA regimen (n=1123). After a median follow-up time of 188 days, the primary and secondary outcomes occurred in 5 (0.4%) and 17 (1.5%) patients (adjusted HR (adjHR) 0.31, 95% CI 0.11 to 0.86, p=0.03) and 6 (0.5%) and 22 (2%) patients (adjHR 0.26, 95% CI 0.10 to 0.65, p=0.004) in the MRA and control groups, respectively. There were also trends towards lower rates of cardiovascular death (p=0.06) and ventricular fibrillation (p=0.08) in the MRA group.

CONCLUSION

Our analysis suggests that compared with standard therapy, MRA regimens are associated with a reduction of death and death or resuscitated sudden death in STEMI.

Для цитирования: Beygui Farzin, Van Belle Eric, Ecollan Patrick, Machecourt Jacques, Hamm Christian W, Lopez De Sa Estaeban, Flather Marcus, Verheugt Freek W A, Vicaut Eric, Zannad Faiez, Pitt Bertram, Montalescot Gilles. Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction.. Heart (British Cardiac Society). 2018. DOI: 10.1136/heartjnl-2018-312950.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.